Cargando…

Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis

IMPORTANCE: New therapeutic classes of migraine-specific treatment have been developed, including 5-hydroxytryptamine(1F) receptor agonists (lasmiditan) and calcitonin gene-related peptide antagonists (rimegepant and ubrogepant). OBJECTIVE: To compare outcomes associated with the use of lasmiditan,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chun-Pai, Liang, Chih-Sung, Chang, Ching-Mao, Yang, Cheng-Chia, Shih, Po-Hsuan, Yau, Yun-Chain, Tang, Kuo-Tung, Wang, Shuu-Jiun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506232/ https://www.ncbi.nlm.nih.gov/pubmed/34633423 http://dx.doi.org/10.1001/jamanetworkopen.2021.28544

Ejemplares similares

Stroke, Migraine and Triptans: From Bedside to Bench
por: Raschi, Emanuel, et al.
Publicado: (2016)

Headaches related to triptans therapy in patients of migrainous vertigo
por: Prakash, Sanjay, et al.
Publicado: (2008)

Efficacy of frovatriptan as compared to other triptans in migraine with aura
por: Evers, Stefan, et al.
Publicado: (2015)

Treatment adherence among new triptan users: a 2-year cohort study in Taiwan
por: Chen, Ting-Bin, et al.
Publicado: (2014)

Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
por: Etemad, Lida R., et al.
Publicado: (2005)

Migraine predicts physical and pain symptoms among psychiatric outpatients
por: Hung, Ching-I, et al.
Publicado: (2013)

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Network meta-analysis of migraine disorder treatment by NSAIDs and triptans
por: Xu, Haiyang, et al.
Publicado: (2016)

The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up
por: Hung, Ching-I, et al.
Publicado: (2015)

Migraine and greater pain symptoms at 10-year follow-up among patients with major depressive disorder
por: Hung, Ching-I, et al.
Publicado: (2018)

Up to date on the use of triptans for child and adolescent migraine: state of the art
por: Calderoni, Dario, et al.
Publicado: (2001)

Triptans in prevention of menstrual migraine: a systematic review with meta-analysis
por: Hu, Yong, et al.
Publicado: (2013)

Triptans Use for Migraine Headache among Nonelderly Adults with Cardiovascular Risk
por: Alwhaibi, Monira, et al.
Publicado: (2016)

Acute treatment patterns in patients with migraine newly initiating a triptan
por: Lipton, Richard B, et al.
Publicado: (2020)

Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans
por: Knievel, Kerry, et al.
Publicado: (2019)

Lasmiditan for Patients with Migraine and Contraindications to Triptans: A Post Hoc Analysis
por: Krege, John H., et al.
Publicado: (2022)

The Morphological and Dynamic Changes of Ultrasound in the Evaluation of Effects of Oral Steroids Treatment for Patients with Carpal Tunnel Syndrome
por: Yau, Yun-Chain, et al.
Publicado: (2021)

The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder
por: Hung, Ching-I, et al.
Publicado: (2014)

Migraine with active headache was associated with other painful physical symptoms at two-year follow-up among patients with major depressive disorder
por: Hung, Ching-I, et al.
Publicado: (2019)

Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks
por: Rubino, Elisa, et al.
Publicado: (2022)

Brainstem (1)H-MR spectroscopy in episodic and chronic migraine
por: Lai, Tzu-Hsien, et al.
Publicado: (2012)

Comorbidities of Migraine
por: Wang, Shuu-Jiun, et al.
Publicado: (2010)

Non-headache symptoms in migraine patients
por: Chen, Ping-Kun, et al.
Publicado: (2018)

Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring
por: Harris, Gerd Marie, et al.
Publicado: (2022)

Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
por: Diener, Hans-Christoph, et al.
Publicado: (2008)

Theoretical analysis of headache recurrence in patients administered triptans for migraine based on receptor occupancy
por: Tokuoka, Kentaro, et al.
Publicado: (2015)

Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes
por: Bérard, Anick, et al.
Publicado: (2021)

Perinatal use of triptans and other drugs for migraine—A nationwide drug utilization study
por: Tauqeer, Fatima, et al.
Publicado: (2021)

Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
por: Kogelman, Lisette J. A., et al.
Publicado: (2023)

All triptans are not the same
por: Rapoport, Alan M., et al.
Publicado: (2001)

Clinical experience with triptans
por: Zanchin, Giorgio, et al.
Publicado: (2001)

Different characteristics of triptans
por: Pini, Luigi A., et al.
Publicado: (2004)

Success and failure of triptans
por: Saxena, Pramod R., et al.
Publicado: (2001)

Selecting the preferred triptans
por: McCrory, Douglas C., et al.
Publicado: (2004)

Patients’ preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine
por: Dowson, A. J., et al.
Publicado: (2005)

Adding acute treatments for patients on triptans: Results of the American Migraine Prevalence & Prevention (AMPP) study
por: Lipton, RB, et al.
Publicado: (2013)

Hair analysis for detection of triptans occasionally used or overused by migraine patients—a pilot study
por: Ferrari, Anna, et al.
Publicado: (2016)

Managing migraine with over-the-counter provision of triptans: the perspectives and readiness of Western Australian community pharmacists
por: Booth, Shaid, et al.
Publicado: (2019)

Predicting the response to a triptan in migraine using deep attack phenotyping: A feasibility study
por: Viana, Michele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h70rkbpihqggao9h2a7f9fdof2